🇺🇸 FDA
Patent

US 7456222

Anti tubercular drug: compositions and methods

granted A61KA61K31/13A61K31/132

Quick answer

US patent 7456222 (Anti tubercular drug: compositions and methods) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/13, A61K31/132, A61K31/137, A61P